ONO Pharmaceutical Co Financial Overview
ONO Pharmaceutical Co's market cap is currently $6.54B. The company's EPS TTM is $0.305344; its P/E ratio is 18.35; and it has a dividend yield of 4.16%. ONO Pharmaceutical Co is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.27. See an overview of income statement, balance sheet, and cash flow financials.
